These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 2141994)

  • 1. The prevention of Down's syndrome in the south western region of England 1975-1985.
    Wilson N; Bickley D; McDermott A
    West Engl Med J; 1990 Mar; 105(1):15-7. PubMed ID: 2141994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for antenatal detection of Down's syndrome.
    Wyllie JP; Madar RJ; Wright M; Burn J; Wren C
    Arch Dis Child Fetal Neonatal Ed; 1997 Jan; 76(1):F26-30. PubMed ID: 9059182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels.
    DiMaio MS; Baumgarten A; Greenstein RM; Saal HM; Mahoney MJ
    N Engl J Med; 1987 Aug; 317(6):342-6. PubMed ID: 2439909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of first year (1989) of a national register of Down's syndrome in England and Wales.
    Mutton DE; Alberman E; Ide R; Bobrow M
    BMJ; 1991 Nov; 303(6813):1295-7. PubMed ID: 1836152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal screening for Down's syndrome with use of maternal serum markers.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
    N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Down's syndrome live births and antenatal diagnoses in England and Wales from 1989 to 2008: analysis of data from the National Down Syndrome Cytogenetic Register.
    Morris JK; Alberman E
    BMJ; 2009 Oct; 339():b3794. PubMed ID: 19858532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using decision analysis to compare policies for antenatal screening for Down's syndrome.
    Fletcher J; Hicks NR; Kay JD; Boyd PA
    BMJ; 1995 Aug; 311(7001):351-6. PubMed ID: 7640539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
    Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
    N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective audit of different antenatal screening policies for Down's syndrome in eight district general hospitals in one health region.
    Wellesley D; Boyle T; Barber J; Howe DT
    BMJ; 2002 Jul; 325(7354):15. PubMed ID: 12098722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Socioeconomic and state-level differences in prenatal diagnosis and live birth prevalence of Down's syndrome in the United States.
    Khoshnood B; Pryde P; Blondel B; Lee KS
    Rev Epidemiol Sante Publique; 2003 Dec; 51(6):617-27. PubMed ID: 14967994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prospects for "preventing" Down's syndrome in an English region.
    Forster DP
    Rev Epidemiol Sante Publique; 1980 Dec; 28(4):423-30. PubMed ID: 6452660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
    Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
    Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the disutility ratio in prenatal screening for Down's syndrome.
    van der Meulen JH; Mol BW; Pajkrt E; van Lith JM; Voorn W
    Br J Obstet Gynaecol; 1999 Feb; 106(2):108-15. PubMed ID: 10426675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability of statistics on Down's syndrome notifications.
    Huang T; Watt HC; Wald NJ; Morris JK; Mutton D; Alberman E
    J Med Screen; 1997; 4(2):95-7. PubMed ID: 9275267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal genetic services for Down's syndrome: access and provision in 1990-1991. Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders.
    Williamson P; Harris R; Church S; Fiddler M; Rhind J
    Br J Obstet Gynaecol; 1996 Jul; 103(7):676-83. PubMed ID: 8688395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Screening by maternal serum markers for Down's syndrome].
    Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down's syndrome: current screening techniques.
    White RS
    South Med J; 1989 Dec; 82(12):1483-6. PubMed ID: 2480649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal genetic diagnosis of Down's syndrome.
    Abbott MA; Benn P
    Expert Rev Mol Diagn; 2002 Nov; 2(6):605-15. PubMed ID: 12465456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.